Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol (2016)
- Authors:
- USP affiliated authors: ZUARDI, ANTONIO WALDO - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.3389/fphar.2016.00359
- Subjects: CANABINOIDES; EPILEPSIA; ELETROFISIOLOGIA
- Keywords: Cannabidiol; Epilepsy; Cbd; Intoxication; Refractory reriod; Electrophysiological
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Frontiers in Pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 7, art. 359, 2016
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
CRIPPA, José Alexandre de Souza et al. Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol. Frontiers in Pharmacology, v. 7, 2016Tradução . . Disponível em: https://doi.org/10.3389/fphar.2016.00359. Acesso em: 02 jun. 2024. -
APA
Crippa, J. A. de S., Crippa, A. C. S., Hallak, J. E. C., Martín-Santos, R., & Zuardi, A. W. (2016). Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol. Frontiers in Pharmacology, 7. doi:10.3389/fphar.2016.00359 -
NLM
Crippa JA de S, Crippa ACS, Hallak JEC, Martín-Santos R, Zuardi AW. Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 jun. 02 ] Available from: https://doi.org/10.3389/fphar.2016.00359 -
Vancouver
Crippa JA de S, Crippa ACS, Hallak JEC, Martín-Santos R, Zuardi AW. Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol [Internet]. Frontiers in Pharmacology. 2016 ; 7[citado 2024 jun. 02 ] Available from: https://doi.org/10.3389/fphar.2016.00359 - Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus
- Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
- Cannabidiol normalizes caspase 3, synaptophysin, and mitochondrial fission protein DNM1L expression levels in rats with brain iron overload: implication for neuroprotection
- Cannabidiol prevents motor and cognitive impairments induced by reserpine in rats
- Cannabinoid-based therapies and brain development: potential harmful effect of early modulation of the endocannabinoid system
- Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol: an anxiolytic or an antipsychotic new drug?
- Glutamate-N-methyl-D-aspartate receptor modulation and minocycline for the treatment of patients with schizopherenia: an update
- Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
Informações sobre o DOI: 10.3389/fphar.2016.00359 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
